tetramethylpyrazine has been researched along with Lung Neoplasms in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 5 (45.45) | 24.3611 |
| 2020's | 3 (27.27) | 2.80 |
| Authors | Studies |
|---|---|
| Ai, Y; Ding, K; Huang, Z; Kang, F; Lai, Y; Li, J; Peng, S; Ren, C; Tian, J; Zhang, Y; Zhu, B | 1 |
| Li, X; Lin, D; Lin, J; Lin, Z; Wang, P; Xu, J; Zhang, D; Zhou, C | 1 |
| Ding, R; Fan, P; Guo, M; Wang, G; Xu, D; Xu, X; Zhang, E; Zheng, Y | 1 |
| Bai, Y; Gao, J; Hu, D; Liang, C; Liu, Y; Wang, F; Wu, J; Zhou, J | 1 |
| Huang, HH; Liu, FB; Ruan, Z; Su, YJ; Wang, J; Zheng, J | 1 |
| Chen, S; Fu, Y; Jia, Y; Jiao, S; Wang, Z; Zang, A | 1 |
| Liang, Y; Lin, Y; Liu, Y; Yin, W; Zhang, J | 1 |
| Chen, L; Gao, M; Lei, N; Lu, Y; Wang, AY; Wu, JM; Xu, B; Zhang, CB; Zhang, LJ; Zhang, WW; Zheng, SZ | 1 |
| Pan, XJ; Xiao, W; Yang, ZH; Zheng, CY; Zhou, SY; Zhu, MX | 1 |
| Feng, J; Sun, R; Tian, Z; Wei, H; Xiao, W; Xu, X; Zhen, C | 1 |
| Chen, SX; Wang, LX; Xing, LL | 1 |
1 trial(s) available for tetramethylpyrazine and Lung Neoplasms
| Article | Year |
|---|---|
[Effects of tetramethylpyrazine on platelet functions of advanced cases of lung carcinoma].
Topics: 6-Ketoprostaglandin F1 alpha; Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Humans; Lung Neoplasms; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Pyrazines; Thromboxane B2 | 1997 |
10 other study(ies) available for tetramethylpyrazine and Lung Neoplasms
| Article | Year |
|---|---|
Discovery of New Monocarbonyl Ligustrazine-Curcumin Hybrids for Intervention of Drug-Sensitive and Drug-Resistant Lung Cancer.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Curcumin; Dose-Response Relationship, Drug; Drug Discovery; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Humans; Lung Neoplasms; Mice; Molecular Structure; Neoplasms, Experimental; Pyrazines; Reactive Oxygen Species; Structure-Activity Relationship; Thioredoxin-Disulfide Reductase | 2016 |
Tetramethylpyrazine-Rhein Derivative inhibits the migration of canine inflammatory mammary carcinoma cells by mitochondrial damage-mediated apoptosis and cadherins downregulation.
Topics: Animals; Apoptosis; Cadherins; Carcinoma; Cell Line, Tumor; Cell Movement; Cell Proliferation; Dogs; Down-Regulation; Lung Neoplasms | 2023 |
Synthesis and in-vitro study of a novel ligustrazine diselenide as a potential chemotherapy drug for lung adenocarcinoma.
Topics: Adenocarcinoma of Lung; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Humans; Lung Neoplasms; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt | 2023 |
Development of novel celastrol-ligustrazine hybrids as potent peroxiredoxin 1 inhibitors against lung cancer.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Humans; Lung Neoplasms; Pentacyclic Triterpenes; Peroxiredoxins; Reactive Oxygen Species; Triterpenes | 2023 |
Tetramethylpyrazine (TMPZ) triggers S-phase arrest and mitochondria-dependent apoptosis in lung cancer cells.
Topics: Apoptosis; bcl-2-Associated X Protein; Caspase 3; Cell Line, Tumor; Cell Proliferation; Humans; Lung Neoplasms; Membrane Potential, Mitochondrial; Mitochondria; Proto-Oncogene Proteins c-bcl-2; Pyrazines | 2018 |
Tetramethylpyrazine inhibits tumor growth of lung cancer through disrupting angiogenesis via BMP/Smad/Id-1 signaling.
Topics: Angiogenesis Inhibitors; Animals; Bone Morphogenetic Proteins; Cell Line, Tumor; Cell Movement; Cell Proliferation; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Humans; Inhibitor of Differentiation Protein 1; Injections, Intraperitoneal; Lung Neoplasms; Mice; Pyrazines; Signal Transduction; Smad Proteins; Time Factors; Xenograft Model Antitumor Assays | 2016 |
IRE1α-TRAF2-ASK1 pathway is involved in CSTMP-induced apoptosis and ER stress in human non-small cell lung cancer A549 cells.
Topics: A549 Cells; Apoptosis; Carcinoma, Non-Small-Cell Lung; Caspases; Cell Cycle; Cell Survival; Endoplasmic Reticulum Chaperone BiP; Endoplasmic Reticulum Stress; Endoribonucleases; Humans; Lung Neoplasms; MAP Kinase Kinase Kinase 5; Mitochondria; Protein Binding; Protein Serine-Threonine Kinases; Pyrazines; RNA, Small Interfering; Signal Transduction; TNF Receptor-Associated Factor 2 | 2016 |
Ligustrazine inhibits B16F10 melanoma metastasis and suppresses angiogenesis induced by Vascular Endothelial Growth Factor.
Topics: Angiogenesis Inhibitors; Animals; Cell Movement; Cell Proliferation; Female; Fibroblasts; Humans; Lung Neoplasms; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Microvessels; Neovascularization, Pathologic; Pyrazines; Rats; Vascular Endothelial Growth Factor A | 2009 |
Inhibition of cyclooxygenase-2 by tetramethylpyrazine and its effects on A549 cell invasion and metastasis.
Topics: Adenocarcinoma; Animals; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclooxygenase 2 Inhibitors; Dinoprostone; Female; Humans; Immunoglobulin G; Lung Neoplasms; Matrix Metalloproteinase 2; Melphalan; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Invasiveness; Pyrazines; Xenograft Model Antitumor Assays | 2012 |
Type two cytokines predominance of human lung cancer and its reverse by traditional Chinese medicine TTMP.
Topics: Adult; Aged; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cytokines; Drugs, Chinese Herbal; Female; Gene Expression; Humans; Ligusticum; Lung Neoplasms; Male; Medicine, Chinese Traditional; Mice; Middle Aged; Pyrazines | 2004 |